FERLAZZO, Guido

FERLAZZO, Guido  

Universita' degli Studi di Messina  

Mostra records
Risultati 1 - 20 di 154 (tempo di esecuzione: 0.032 secondi).
Titolo Data di pubblicazione Autore(i) File
A mixture of bacterial mechanical lysates is more efficient than single strain lysate and of bacterial-derived soluble products for the induction of an activating phenotype in human dendritic cells. 1-gen-2011 Morandi, B; Agazzi, A; D'Agostino, A; Antonini, F; Costa, Gregorio; Sabatini, F; Ferlazzo, Guido; Melioli, G.
A multivariate analysis of Multiple Myeloma subtype plasma cells 1-gen-2021 Bonsignore, M.; Trusso, S.; De Pasquale, C.; Ferlazzo, G.; Allegra, A.; Innao, V.; Musolino, C.; Franco, D.; Maria De Plano, L.; Guglielmino, S. P. P.; Neri, F.; Fazio, E.
A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation 1-gen-2015 Morandi, Fabio; Morandi, Barbara; Horenstein, Alberto L; Chillemi, Antonella; Quarona, Valeria; Zaccarello, Gianluca; Carrega, Paolo; Ferlazzo, Guido; Mingari, Maria Cristina; Moretta, Lorenzo; Pistoia, Vito; Malavasi, Fabio
A PHASE-I STUDY OF INTRAVESICAL CONTINUOUS PERFUSION OF RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH SUPERFICIAL BLADDER- CANCER 1-gen-1995 Ferlazzo, Guido; Magno, Carlo; Lupo, G; Rizzo, M; Iemmo, R; Semino, C; Melioli, G.
A think tank of TINK/TANKs: tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis 1-gen-2014 Bruno, Antonino; Ferlazzo, Guido; Albini, Adriana; Noonan, Douglas M
Acquisition and presentation of tumor antigens by dendritic cells. 1-gen-2015 Bonaccorsi, Irene; Campana, Stefania; Morandi, Barbara; Ferlazzo, Guido
Adaptative immunotherapy of advanced solid tumors 1-gen-1999 Semino, C; Ferlazzo, Guido; Ratto, Gb; Melioli, G.
Adherent neoplastic cells grown at confluence downregulate HLA class I expression and enhance their susceptibility to lysis mediated by natural killer cells 1-gen-1997 FERLAZZO G.; SEMINO C; QUARTARONE G; PIETRA G; MELIOLI G
Adoptive immunotherapy of advanced solid tumors: An eight year clinical experience 1-gen-1999 Semino, C; Martini, L; Queirolo, P; Cangemi, G; Costa, R; Alloisio, A; Ferlazzo, Guido; Sertoli, Mr; Reali, Um; Ratto, Gb; Melioli, G.
An historical overview: The discovery of how NK cells can kill enemies, recruit defense troops, and more 1-gen-2019 Vitale, M.; Cantoni, C.; Della Chiesa, M.; Ferlazzo, G.; Carlomagno, S.; Pende, D.; Falco, M.; Pessino, A.; Muccio, L.; De Maria, A.; Marcenaro, E.; Moretta, L.; Sivori, S.
Analysis of HLA-class-I specific natural killer cell receptors expressed on T lymphocytes infiltrating non-small-cell lung cancer 1-gen-2001 Semino, C; Ferlazzo, Guido; Ratto, Gb; Melioli, G.
Anti-SARS-CoV2 IgG are present in the amniotic fluid of both infected and vaccinated women at second trimester of pregnancy: a cohort study 1-gen-2023 La Fauci, Laura; Cavaliere, Riccardo; Romeo, Paola; Alibrandi, Angela; Ferlazzo, Guido; D'Anna, Rosario; Corrado, Francesco
Arginase 2 is expressed by human lung cancer, but it neither induces immune suppression, nor affects disease progression 1-gen-2008 ROTONDO R; MASTRACCI L; PIAZZA T; BARISIONE G; FABBI M; CASSANELLO M; COSTA R; MORANDI B; ASTIGIANO S; CESARIO A; SORMANI MP; FERLAZZO G.; GROSSI F; RATTO GB; FERRINI S; FRUMENTO G
Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer 1-gen-2020 Ottonello, S.; Genova, C.; Cossu, I.; Fontana, V.; Rijavec, E.; Rossi, G.; Biello, F.; Dal Bello, M. G.; Tagliamento, M.; Alama, A.; Coco, S.; Boccardo, S.; Vanni, I.; Ferlazzo, G.; Moretta, L.; Grossi, F.; Mingari, M. C.; Carrega, P.; Pietra, G.
Attenuated immune control of Epstein–Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15 1-gen-2021 Zdimerova, H.; Murer, A.; Engelmann, C.; Raykova, A.; Deng, Y.; Gujer, C.; Ruhl, J.; Mchugh, D.; Caduff, N.; Naghavian, R.; Pezzino, G.; Capaul, R.; Zbinden, A.; Ferlazzo, G.; Lunemann, J. D.; Martin, R.; Chatterjee, B.; Munz, C.
Biological parameters in breast cancer 1-gen-1996 Costa, Gregorio; Lascari, G; Aragona, Marcello; Ferlazzo, Guido; Adamo, V; Gangemi, R; Geraci, O; Pastura, G; Mesiti, M; Castagnetta, L.
Biological parameters in breast cancer. 1-gen-1996 Costa G;Lascari G;Aragona M;Ferlazzo G;Adamo V;Gangemi R;Geraci O;Pastura G;Mesiti M;Castagnetta L
CD56(bright) CD16(-) killer Ig-like receptor(-) NK cells display longer telomeres and acquire features of CD56(dim) NK cells upon activation 1-gen-2007 Romagnani, C; Juelke, K; Falco, M; Morandi, B; D'Agostino, A; Costa, R; Ratto, G; Forte, G; Carrega, Paolo; Lui, G; Conte, R; Strowig, T; Moretta, A; Munz, C; Thiel, A; Moretta, L; Ferlazzo, Guido
CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph. 1-gen-2014 Carrega, Paolo; Bonaccorsi, Irene; Di Carlo, E; Morandi, B; Paul, P; Rizzello, Valeria; Cipollone, G; Navarra, Giuseppe; Mingari, Mc; Moretta, L; Ferlazzo, Guido
CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells. 1-gen-2010 Juelke K; Killig M; Luetke-Eversloh M; Parente E; Gruen J; Morandi B; Ferlazzo G; Thiel A; Schmitt-Knosalla I; Romagnani C.